WHO ICTRP trial
To compare the effect of IV Lignocaine 60mg versus 30mg pretreatment for…
CTRI/2025/08/093677 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2025/08/093677 |
|---|---|
| Public title | To compare the effect of IV Lignocaine 60mg versus 30mg pretreatment for preventing the pain of Propofol injection. |
| Scientific title | Comparitive study between effect of IV Lignocaine 60mg versus 30mg as pretreatment for prevention of pain during Propofol induction - NIL |
| Primary sponsor | Sapthagiri Institute of Medical Sciences and Research Centre |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: 3- Administration |
| Interventions | Intervention1: Intravenous lignocaine 30mg: IV lignocaine either 30mg is given before Injecting IV Propofol Control Intervention1: Intravenous lignocaine 60mg: IV lignocaine 60mg is given before injecting IV Propofol |
| Registration date | Aug 26, 2025 |
| Target size | 50 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: